U.S. Dermatology Imaging Devices Market (By Modality: Digital Photographic Imaging, OCT, Dermatoscope; By Application: Skin Cancers, Inflammatory Dermatoses) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

U.S. Dermatology Imaging Devices Market Size and Growth

The U.S. dermatology imaging devices market size was estimated at around USD 0.83 billion in 2023 and it is projected to hit around USD 2.95 billion by 2033, growing at a CAGR of 13.53% from 2024 to 2033. The U.S. dermatology imaging devices market is a rapidly growing sector within the medical imaging industry. These devices are used for the diagnosis, monitoring, and treatment of various skin conditions, including melanoma, psoriasis, and eczema. The rising prevalence of skin disorders, coupled with advancements in imaging technology, is driving the growth of this market.

Key Pointers

• By Modality, the dermatoscope segment generated the maximum market share of 42% in 2023.
• By Modality, the digital photographic imaging is estimated to expand the fastest CAGR from 2024 to 2033.
• By Application, the skin cancer segment captured the maximum market share of 49% in 2023.
• By Application, the plastic and reconstructive surgery segment is estimated to expand the fastest CAGR from 2024 to 2033.
• By End Use, the hospital segment accounted for the largest revenue share of 44% in 2023.
• By End Use, the dermatology centers segment is anticipated to grow at the noteworthy CAGR during the forecast period.

U.S. Dermatology Imaging Devices Market Growth Factors

The U.S. dermatology imaging devices market is experiencing significant growth driven by the rising incidence of skin cancer, particularly melanoma, is driving the demand for advanced imaging solutions that facilitate early detection and improved treatment outcomes. Technological advancements in imaging devices, such as high-resolution digital dermatoscopes and confocal microscopes, are enhancing diagnostic accuracy and efficiency, further propelling market growth. Additionally, increased awareness about skin health and the importance of regular screenings, supported by public health initiatives, is boosting the adoption of dermatology imaging devices. The aging population, which is more prone to skin conditions, is also contributing to the market expansion. Together, these factors are fostering a robust growth environment for dermatology imaging devices in the U.S.

What are the Key Trends in U.S. Dermatology Imaging Devices Market?

The U.S. dermatology imaging devices market is witnessing several key trends that are shaping its evolution. One significant trend is the integration of artificial intelligence (AI) and machine learning (ML) technologies into imaging devices, enhancing diagnostic capabilities and enabling more precise and efficient analysis of skin conditions. The market is also seeing a shift towards portable and user-friendly devices, making advanced dermatological imaging more accessible to a wider range of healthcare providers, including smaller clinics and dermatology practices.

Additionally, there is a growing emphasis on teledermatology, where imaging devices are used to facilitate remote consultations and diagnostics, a trend accelerated by the COVID-19 pandemic. Furthermore, increasing investment in research and development by key market players is leading to continuous innovation and the introduction of next-generation imaging solutions. These trends are collectively driving the advancement and adoption of dermatology imaging devices across the U.S.

Challenges in U.S. Dermatology Imaging Devices Market

• Integration and Compatibility Issues: Ensuring that new imaging devices are compatible with existing healthcare IT systems and electronic health records can pose challenges.
• Patient Privacy Concerns: The use of digital imaging and data storage raises concerns about patient privacy and the security of sensitive health information.
• Limited Awareness and Adoption: Despite technological advancements, there is still a lack of awareness and adoption of these devices among some healthcare providers and patients.

Modality Insights

The dermatoscope segment led the market with the largest revenue share of 42% in 2023. Dermatoscopes provide dermatologists with a magnified and illuminated view of skin lesions, enabling them to identify characteristic patterns and structures not visible to the naked eye. This enhanced visualization improves diagnostic accuracy, particularly in differentiating benign from malignant skin lesions, thus reducing the need for unnecessary biopsies. Continuous improvements in dermatoscope technology, such as higher resolution, better illumination, and integration with digital imaging, have further enhanced their diagnostic capabilities.

The digital photographic imaging market is growing at the fastest CAGR over the forecast period. This growth is attributed to the ease of availability of smartphones, which allow for capturing high-quality images of skin lesions, and handheld cameras that can produce high-resolution images documenting the patient's condition. The rise in skin cancer cases and the growing demand for non-invasive diagnostic procedures are also driving this segment's growth. Devices like MoleScope, FotoFinder, and Canfield VISIA, which provide high-resolution skin images, are widely used in the U.S. market, allowing dermatologists to identify and track changes in the skin over time.

Application Insights

The skin cancer segment led the market with the largest revenue share of 49% in 2023, driven by the higher prevalence and increased awareness of skin cancers. According to the American Cancer Society, skin cancers, primarily basal and squamous cell types, are the most prevalent forms of cancer in the U.S., with around 5.4 million cases diagnosed annually. The increasing incidence of skin cancer is expected to drive demand for dermatology imaging devices. Technological advancements, such as optical coherence tomography (OCT) and confocal microscopy, are transforming the diagnosis of skin disorders by providing high-resolution images of skin layers in a non-invasive manner.

The plastic and reconstructive surgery segment is anticipated to grow at a significant CAGR over the forecast period, driven by the rising demand for minimally invasive procedures and technological innovations in the field. As cosmetic surgeries continue to increase, there is a growing need for accurate imaging technologies to achieve optimal results. According to the American Society of Plastic Surgeons, the number of cosmetic and reconstructive procedures performed in the U.S. increased significantly in 2022, with a total of 26.2 million procedures, representing a 19% increase since 2019.

End Use Insights

The hospital segment accounted for the largest revenue share of 44% in 2023. This is due to the widespread adoption of advanced dermatology imaging devices in hospitals, enabling dermatologists to accurately diagnose and effectively treat various skin conditions, including skin cancer. Hospitals employ highly trained and experienced dermatologists and imaging technicians, ensuring optimal utilization of these advanced technologies. They have the necessary infrastructure, resources, and expertise to provide comprehensive diagnosis, treatment, and follow-up care. For instance, the renewed collaboration between GE HealthCare and Hartford HealthCare in March 2024 is expected to strengthen the hospital segment, ensuring access to GE HealthCare's advanced dermatology imaging technologies and enhancing the quality of care provided to patients.

The dermatology centers segment is expected to experience significant growth during the forecast period. This growth can be attributed to the increasing popularity of dermatology centers among patients seeking specialized care for skin-related issues. These centers offer expertise and advanced imaging technologies, such as dermatoscopes and digital photographic imaging systems, which may not always be available in hospitals. These devices provide high-resolution images of the skin, enabling dermatologists to identify characteristic patterns and structures that are not visible to the naked eye.

Who are the Top Manufactures in U.S. Dermatology Imaging Devices Market?

• Caliber Imaging and Diagnosis.
• Canfield Scientific, Inc.
• Clarius
• Cortex Technology
• Courage+Khazaka electronic GmbH
• Comp6
• DermLite
• DRAMIŃSKI S. A.
• e-con Systems Inc.
• FotoFinder Systems GmbH
• GE HealthCare
• Koninklijke Philips N.V.
• Longport, Inc.
• Michelson Diagnostics Ltd (MDL)
• VisualSonics

Recent Market News

• In June 2024, the U.S. FDA granted Breakthrough Device Designation to Enspectra Health’s AI-powered VIO Skin Platform. This platform integrates FDA-cleared VIO technology with VIO.ai NMSC software, designed to assist physicians in assessing lesions suspected of being basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in high-risk populations. This designation underscores the platform's potential to significantly improve the accuracy and speed of skin cancer diagnostics.
• In March 2024, FotoFinder Systems, a global leader in skin imaging solutions and an EMZ Partners portfolio company, finalized an agreement to acquire DermLite, a manufacturer of handheld dermatoscopes. This acquisition marks EMZ Partners' first investment in the U.S. and enhances FotoFinder's product portfolio, further solidifying its position in the dermatology imaging market.
• In January 2024, GE HealthCare announced an agreement to acquire IMACTIS, a French company specializing in computed tomography (CT) interventional guidance technology. This acquisition will bolster GE HealthCare's interventional guidance offerings, providing more accurate and efficient procedures for interventional radiologists and hospitals, thereby expanding its market reach and technological capabilities.
• In June 2023, DeepX Diagnostics received FDA approval for its digital dermatoscopy device, DermoSight. This approval allows DeepX Diagnostics to offer teledermatology screening for suspicious skin cancer lesions in the United States. Having already assessed over 180,000 skin lesions in Europe, the company’s entry into the U.S. market marks a significant expansion of its teledermatology and skin cancer diagnostic services, leveraging digital imaging to enhance early detection and treatment.

U.S. Dermatology Imaging Devices Market Segmentation:

By Modality

• Digital Photographic Imaging
• Optical Coherence Tomography (OCT)
• Dermatoscope
• High Frequency Ultrasound
• Others

By Application

• Skin Cancers
• Inflammatory Dermatoses
  • Skin psoriasis
  • Eczema (Atopic dermatitis)
  • Others
• Plastic & Reconstructive Surgery
• Others

By End Use

• Hospitals
• Dermatology centers
• Specialty Clinics

By Region

• West
• Midwest
• Northeast
• Southwest
• Southeast